Medicines for Europe

Value added medicines: A patient-centric approach to healthcare

In this podcast created by Medicines for Europe, the presenter informally discusses a key topic related to off-patent medicines with two or more experts, focusing on generics, biosimilar and value added medicines.

Medicines shortages: Causes and recommendations

Medicines shortages have multiple causes. We at Medicines for Europe have identified some solutions that can ease the situation.

Fighting antimicrobial resistance requires action on many fronts

Koen Laenen, Medicines for Europe, highlights what it takes to tackle the issue of antimicrobial resistance - one of the biggest health threats in Europe and beyond. Measures include ensuring that patient have access to the right antibiotics and reducing antibiotics in the environment.

Access to medicines: Let’s have better care, for more patients

Marc-Alexander Mahl is President of Medicines for Europe. Europe’s healthcare model is under pressure. Populations are ageing in Europe – with the number of Europeans aged 65 or over set to rise by 45 million between 2015 and 2050.(1) This...

Increasing access to medicines: Better care for more patients

Download PDF  

Due to austerity measures and weak growth, our ageing populations and rising healthcare costs driven by new, expensive treatments, European healthcare faces unprecedented and growing pressures.